Health Care

Peninsula Pharmaceuticals

Penin­sula is a bio­phar­ma­ceu­ti­cal com­pany focused on the devel­op­ment and com­mer­cial­iza­tion of antibi­otics to treat life-​​threatening infec­tions. The Company’s mis­sion is to develop opti­mal anti-​​infective ther­a­pies that offer improved effi­cacy, dos­ing and safety char­ac­ter­is­tics over exist­ing ther­a­pies. In addi­tion to DBL Part­ners, investors include Canaan Part­ners and Domain Associates.

Penin­sula was acquired by John­son & John­son on June 30th, 2005.

Peninsula Pharmaceuticals
1751 Harbor Bay Parkway
Alameda, CA 94502

« Back to Portfolio